Interleukin-1{alpha} and -{beta} modulation of luteinized human granulosa cell oestrogen and progesterone biosynthesis

This study was designed to test the hypothesis that inter-leukin-1(IL-1) and directly affect progesterone, and oestradiol productionin cultures of purified human granulosa cells. Luteinized granulosacells were obtained from women during in-vitro fertilizationcycles. Granulosa cells with and without associated white bloodcells were cultured in the presence of IL-1 and IL-1 (0.5–50ng/ml) for 48 h. Media were changed at 24 h intervals and assayedfor progesterone and oestradiol. In separate experiments, granulosacell viability was assessed with the tetrazolium salt reductionassay, haemocytometer cell counts, and Trypan blue dye exclusion.Our results indicate that progesterone synthesis by basal andhuman chorionic gonadotrophin (HCG)-stimulated granulosa cellsco-cultured with white blood cells was inhibited by 5.0 ng/mlof IL-1 and IL-1 at 48 h of culture. In the presence of whiteblood cells, granulosa cell oestradiol synthesis was inhibitedby IL-1 but not IL-1. Oestradiol was inhibited after both 24and 48 h of culture and was maximally affected by 5.0 ng/mlof IL-1. In contrast, basal and HCG-stimulated oestradiol productionby granulosa cells cultured free of white blood cells was inhibitedonly by IL-1. IL-1 at 5.0 ng/ml produced maximal inhibitionof basal oestradiol (57%) and HCG-stimulated oestradiol (41%)production at 48 h of culture. Gonadal steroid inhibition byIL-1 and IL-1 was not mediated through cytotoxic or antiproliferativeeffects on granulosa cells. Specificity of the granulosa cellresponse to IL-1 and IL-1 was demonstrated by abrogation ofsteroid inhibition with anti-IL-1 and IL-1 neutralizing antibodies.In conclusion, IL-1 directly inhibited the production of oestradiolby human ovarian granulosa cells. IL-1 and IL-1 also exertedindirect effects on steroid production via white blood cellsthat are usually present in granulosa cell cultures if stepsare not taken to remove them. These data support the hypothesisthat cytokines play an important role in intra-ovarian regulationof steroid biosynthesis.     

Reactive oxygen species stimulate prostaglandin F2 alpha production in human endometrial stromal cells in vitro

BACKGROUND: The present study was undertaken to investigatethe effect of reactive oxygen species on prostaglandin F2 (PGF2)production by human endometrial stromal cells (ESC). METHODSAND RESULTS: Isolated ESC were incubated with hydrogen peroxide,which induces lipid peroxidation. Hydrogen peroxide increasedboth intracellular and medium concentrations of PGF2 (P <0.01). A time course study showed that hydrogen peroxide significantlyincreased PGF2 concentrations in the medium after 6 h incubation(P < 0.01), after which no further increase was observed.To study whether the increase in PGF2 production caused by hydrogenperoxide was mediated by cyclooxygenase, ESC were incubatedwith indomethacin (0.5 µg/ml), an inhibitor of cyclooxygenase,in the presence of hydrogen peroxide. Indomethacin significantlyblocked the increases in PGF2 production caused by hydrogenperoxide (P < 0.01). Hydrogen peroxide also increased PGF2production by decidualized ESC (P < 0.01), induced by theincubation with medroxyprogesterone acetate (10^–6 mol/l)and oestradiol (10^–8 mol/l). CONCLUSIONS: Reactive oxygenspecies stimulate PGF2 production in ESC, suggesting that theymight influence endometrial function by regulating PGF2 production.     

Integrins and adhesion mlecules: Cell adhesion molecules on the oocyte and preimplantation human embryo

The presence of cell adhesion molecules on human oocytes, earlyembryos, and pre-hatched blastocysts was examined by indirectimmunofluorescence and compared to the distribution found onfirst trimester villous placenta with the same antibodies. Sixintegrin subunits (3, V, 1, 3, 4, 5) were observed consistentlythroughout preimplantation development. Evidence was also obtainedfor the presence of integrin subunits 2, 4, L, 2, and 7 on asmall number of oocytes. A more restricted developmental analysisof E-cadherin, ICAM-1, NCAM, and VCAM-1 demonstrated that thesecell adhesion molecules are also present on oocytes and earlyembryos. L-selectin was detected on oocytes but was not foundon 8-cell embryos. The oocyte and early blastomeres have complexsurfaces in which the integrin and CAM families are represented.     

Current concepts of the roles of follicle stimulating hormone and luteinizing hormone in folliculogenesis

Around 400 follicles sequentially mature and ovulate duringan average women‘s reproductive lifetime. From birth tothe menopause, the other 99.98% of her follicles begin developmentbut never complete it. Instead they default to atresia due toinadequate stimulation by follicle stimulating hormone (FSH).Follicular growth to the stage of antrum formation (0.25 mmdiameter) is independent of gonadotrophic stimulation. Antrumformation and further growth to the stage at which folliclesbecome potentially able to begin pre-ovulatory development (2–5mm diameter) require tonic stimulation by FSH. Before onsetof puberty, blood concentrations of FSH do not rise sufficientlyto sustain development beyond this stage, therefore all antralfollicles become atretic. After puberty, as each menstrual cyclebegins, FSH concentrations rise beyond a critical ‘threshold’and multiple follicles are recruited to begin pre-ovulatorydevelopment. Due to increases in its responsiveness to FSH andluteinizing hormone (LH), one of these follicles becomes selectedto ovulate while the remainder become atretic. At mid-follicularphase, the dominant follicle reaches 10 mm in diameter and increasinglysynthesizes oestradiol. Tonic stimulation by FSH and LH, underpinnedby local paracrine signalling, maintains oestrogen secretionby the dominant follicle, which grows to 20 mm in diameter beforeit ovulates in response to the mid-cycle LH surge. The development-relatedresponse to LH shown by the pre-ovulatory follicle raises thepossibility that exogenous LH might be used as an adjunct totherapy with exogenous FSH in clinical ovulation induction regimenswhere the aim is to induce monovulation.     

Development and Validation of a radioimmunoassay for human secretory 'pregnancy-associated endometrial {alpha}2-globulin' ({alpha}2-PEG) and detection in serum during pregnancy

A specific and sensitive radioimmunoassay has been developedfor pregnancy-associated endometrial ²-globulin (²-PEG), themajor secretory protein of the human endometrium during themid- to lateluteal phase of the menstrual cycle and first trimesterof pregnancy. This assay enabled ²-PEG to be measured in thecytosolic extracts of endometrium, am-niotic fluid, seminalplasma and in pregnancy sera. The concentration of aPEG in cytosolsprepared from mid-secretory endometrium was 44-fold higher thanin those from proliferative endometrium and a further 30-foldincrease during the first trimester in comparison with mid-secretoryendometrium. Levels of ²-PEG in amniotk fluid (15-20 weeks)and seminal plasma were 15 ? 4 and 55 ? 7 /tg/ml, respectively.With the exception of sera, where ²-PEG was undetectable usingrocket immunoelectrophoresis, estimates of arPEG levels in thesecompartments, measured by rocket immunoelectrophoretic and RIAassays were comparable, although for seminal plasma 2.5-foldhigher estimates were obtained by RIA. Detectable levels ofa2-PEG were obtained in 253 of 275 (927percnt;) pregnancy seratested. During pregnancy, peak levels were detected betweenweeks 6 and 11 but these represented only 2% of the levels detectedin amniotk fluid. These observations support evidence from in-vitrostudies that a2-PEG is a product of the secretory glandularepithelium, a tissue prominent in the first trimester and whoseprincipal secretory route during pregnancy is into the amnioticfluid. The potential clinical use of serum ²-PEG measurementsand the possible function of ²-PEG in pregnancy is discussed.     

Molecular aspects of implantation: Human trophoblast adhesion to matrix proteins: inhibition and signal transduction

At the time of implantation, the extracellular matrix proteinslaminin and fibronectin are abundant in the decidua and aredistributed pericellularly around each individual stromal cell.First trimester human trophoblast expresses both laminin andfibronectin receptors, specifically the ₁₁, ₅₁, ₆₁ and ₆₄ integrinheterodimers. In this study we have demonstrated that in-vitroadhesion of first trimester human trophoblast to purified extracellularmatrix proteins and to purified decidual stromal cell monolayerscan be inhibited by monoclonal antibodies directed against appropriateintegrin subunits and by synthetic peptides containing an arginine-glycine-asparticacid sequence. Monoclonal antibodies (mAbs) to the ₅ and ₁ integrinsubunits and a synthetic peptide significantly inhibited adhesionto fibronectin. Binding of trophoblast to laminin was blockedwith mAbs to the ₆ and ₁ but not ₁ and ₄ integrin subunits.Similarly, integrin-mediated adhesion to monolayers of decidualstromal cells could be blocked with mAbs to the ₅, ₆, ₁ and₄ integrin subunits. Integrin-mediated signal transduction innormal and malignant trophoblast was investigated by Westernblotting. A 115 kDa protein was the major tyrosine phosphorylatedprotein detected in trophoblast after binding to laminin orfibronectin. The profile of tyrosine phosphorylated proteinsdiffered for malignant trophoblast.     

Discrimination between chronological and ovarian age in infertile women aged 35 years and older: predicting pregnancy using basal follicle stimulating hormone, age and number of ovulation induction/intra-uterine insemination cycles

A marked decline in fertility rates has been demonstrated inwomen >35 years of age. We have previously demonstrated theimportance of basal follicle stimulating hormone (FSH) concentrationsplus chronological age to predict pregnancies in women aged40 years undergoing ovula-tion induction therapy. The purposeof the current study was to extend our previous study and determinethe impact of age, basal FSH concentrations and ovulation induction/intra-uterine insemination (IUI) treatment cycles on pregnancyrates in infertile women aged 35 years. This prospective observationalstudy was performed at a tertiary university fertility centre.Assessments of basal hormonal status and ovulation inductionprotocols were performed. The main outcome measured was clinicalpregnancies. A total of 770 treatment cycles in 179 women aged35 years were analysed. The impact of basal FSH concentrationson treatment outcomes could be bifurcated into a favourablegroup (FSH 23 mlU/ml) and a poor prognosis group (FSH 24 mlU/ml).A multivariate logistic regression model was generated whichaccurately predicted pregnancies. There was a high degree ofcorrelation between predicted pregnancies and observed pregnancies(r = 0.86). We conclude that age, number of treatment cyclesand the interaction term basal FSH x age are useful and significantpredictors of pregnancies in patients aged 35 years undergoingovulation induction/IUl therapy.     

Integrins are not involved in the process of human sperm-oolemmal fusion

BACKGROUND: We investigated whether integrins are required forthe human sperm–oocyte binding and fusion processes. METHODS:The expression of several integrin subunits at the human oocyteplasma membrane was investigated using immunofluorescence microscopy,and the functional role of integrins expressed at the humanoocyte surface in sperm–oocyte interaction was studiedusing a zona-free human oocyte binding and fusion assay. A totalof 144 unfertilized oocytes were stained with anti-integrinantibodies and 147 zona-free unfertilized oocytes were inseminatedin the presence of various anti-integrin antibodies that wereexpressed in oocyte plasma membrane. RESULTS: The antibodiesof six integrin subunits (₂, ₃, ₅, ₆, _V, _M) and six integrinsubunits (₁, ₂, ₃, ₄, ₅, ₆) were bound to the surface of fixedunfertilized oocytes. In contrast, the presence of ₁ and ₄ subunitscould not be verified. The human sperm–oocyte bindingwas only partially inhibited by blocking antibodies of ₂, ₃,₅, ₆, _V, _M, ₁, ₂ and ₃ with a maximum of 55% inhibition, butantibodies of ₄, ₅ and ₆ showed no effect on sperm–oolemmalbinding. A similar reduction of the number of fused sperm wasobserved. However, the ratio of fused sperm to total sperm (boundand fused) was not impaired by all integrin antibodies, suggestingthat integrins had no role in the sperm–oolemmal fusionprocess. CONCLUSIONS: These results suggest that one of thebinding mechanisms can be inhibited by integrin antibodies butthat this mechanism does not play an essential role in the humansperm–oolemmal binding and fusion processes. The othermechanisms, insensitive to integrins, may involve both bindingand fusion processes in human oocytes.     

Embryonic resistance to tumour necrosis factor-{alpha} mediated cytotoxicity: novel mechanism underlying maternal immunological tolerance to the fetal allograft

The cytokine tumour necrosis factor- (TNF) has been postulatedto play an essential role in the cytotoxic activity of cell-mediatedimmunity against allogenic or tumour cells invading the host.Several tumour cell lines, however, are resistant to TNF mediatedcytotoxicity and respond paradoxically by cellular proliferationand by autocrine secretion of TNF. In view of the metastaticcharacter of the mammalian embryo, the aim of this study wasto assess the potential of murine embryos to secrete TNF invitro, to express TNF receptors and to resist TNF mediated cytotoxicityduring their in-vitro development to the blastocyst stage. Thepotential of human embryos to secrete TNF in vitro until theblastocyst stage was also investigated. From a total of 11 humanembryos, which were allowed to proceed to blastocyst formation,seven secreted TNF in the range of 2–117 pg/ml/24 h. Atotal of 123 C57BL/6J mouse embryos were studied of which 55%secreted TNF in the range of 1.25–3.95 mg/ml/24 h. Thepresence of high levels of exogenous TNF (10–300 IU) wasnot detrimental to the in-vitro development of murine embryos.Using immunohistochemical techniques, we were not able to detectthe presence of type I or II TNF receptors on the surface ofmurine embryos. Our findings suggest that human and C57BL/6Jmurine embryos have the potential to secrete TNF in vitro duringthe developmental stages leading to blastocyst formation. Inboth species, the presence of TNF in the culture medium didnot cause subsequent necrosis of the conceptus, suggesting thatmammalian embryos may be TNF resistant cell lines. The observedembryonic resistance to TNF may be explained by the absenceof TNF receptors by which the cytotoxic effect is usually mediated.It is suggested that embryonic resistance to physiological concentrationsof TNF released by effectors of the host's immune system, couldbe via a mechanism underlying the maternal immunological toleranceto the fetal allograft.     

Ovary: Immunolocalization of transforming growth factor-{beta}1 and transforming growth factor-{beta}2 in the mouse ovary during gonadotrophin-induced follicular maturation

An immunohistochemical approach was utilized to evaluate thecellular distribution of transforming growth factor-₁ (TGF₁)and transforming growth factor ₂ (TGF₂) at different stagesof follicle development in the prepubertal mouse ovary underthe following conditions: (i) after pregnant mare's serum gonadotrophin(PMSG) treatment; (ii) after PMSG and human chorionic gonadotrophin(HCG) treatment; (iii) after PMSG and HCG treatment plus mating.In the immature ovary, TGFF₁ and TGF₂ immunoreactivities arelocalized in theca and granulosa cells and in oocytes. AfterPMSG treatment, TGF₁ and TGF₂ immunoreactivities are localizedin granulosa cells; in addition, TGF₂ staining is noted in thematrix surrounding antral cells. Staining for both TGF₁ andTGF₂ drops in the theca but persists in the oocyte. PMSG plusHCG treatment results in a significant increase in TGF₁ andTGF₂ immunoreactivity in the theca and in the maintenance ofTGF₁ staining in both basal granulosa cells and cumulus cellswhereas TGF₂ immunoreactivity is essentially localized in thematrix surrounding cumulus cells. Staining for TGF₁ and TGF₂persists in the oocyte. Following PMSG plus HCG treatment andmating, TGF₁ immunoreactivity is localized in the luteal cellsof corpora lutea and TGF₂ shows a similar localization pattern.This study provides evidence that TGF₁ and TGF₂ peptides areexpressed in specific cell types during induced follicular maturationin the mouse ovary.     

Genetics: Preimplantation diagnosis of cystic fibrosis by simultaneous detection of the W1282X and {Delta}F508 mutations

W1282X (W) and F508 () are the two most common mutations ofthe cystic fibrosis Israeli population. Patients who are homozygotes(WW and ) as well as compound heterozygotes (W) present a severephenotype of the disease. In the present study, we have developeda polymerase chain reaction (PCR)-based method for the detectionof both mutations simultaneously in a single blastomere. Unfertilizedhuman oocytes and single polyspermic blastomeres were subjectedto a two-round PCR amplification: a first round of multiplexPCR followed by a second round of nested PCR, done seperatelyat each locus. Clear signals at both loci were obtained in 51%(47/65) of oocytes and 69% (24/35) of blastomeres. The genotypeof the single cell analysed was determined by endonuclease digestionof the W products and by heteroduplex formation of the F products.This diagnostic system will allow the identification of affectedembryos (WW, , W) as well as phenotypically normal carriers(W++), and therefore may be used for cystic fibrosis preimplantationdiagnosis in families who carry either or both mutations     

Endocrinology: Serum concentrations of dimeric inhibin during the spontaneous human menstrual cycle and after treatment with exogenous gonadotrophin

A recently described two-site enzyme immunoassay incorporatinga pre-assay oxidation step was validated and used to measureserum concentrations of dimeric inhibin in five normally cyclingwomen and in 13 women undergoing gonadotrophin therapy. Recombinanthuman inhibin A (standard) gave an assay response curve whichwas parallel to those for human serum samples and recovery ofexogenous inhibin added to serum samples before assay was quantittive(109±8%, n=11). During the normal menstrual cycle dimericinhibin concentration increased from 9.0±2.0 pg/ml duringthe early follicular phase to reach a mid-cycle peak of 55.3±11.1pg/ml coincident with the pre-ovulatory gonadotrophin surge.After falling to 27.9 ± 5.7 pg/ml 1 day after the luteinizinghormone surge, inhibin then rose in parallel with serum progesteroneto reach a peak value of 115.6 ± 19.3 pg/ml during themid-luteal phase, before falling to 14.1±4.9 pg/ml bythe onset of next menses. During the follicular phase, dimericinhibin concentrations were closely correlated with those ofserum oestradiol (r,= 0.69; P< 0.001), whereas during theluteal phase they were most closely correlated with serum progesteroneconcentrations (r = 0.73; P < 0.001). Daily treatment withhuman meno-pausal gonadotrophin promoted a progressive increasein serum dimeric inhibin concentration which increased 20-foldin 6 days. In the same period total-inhibin (measured by radioimmunoassay)increased 5-fold, while serum oestradiol increased 30-fold.Although the assay cross-reacted with dimeric inhibin formsof molecular masses in the range 200–30 kDa, chromatographyof superovulatory human serum revealed that the fully processed 30 kDa form is the predominant circulating form, although aproportion of this (30%) is reversibly associated with serumbinding protein(s).     

Concentration of interleukin-1{beta} correlates with prostaglandin E2 and F2{alpha} in human pre-ovulatory follicular fluid

To investigate the role(s) of interleukin-1 (IL-1) in humanovarian function, we measured the concentrations of IL–1,prostaglandins (PGs) and steroids in follicular fluid of 90stimulated ovaries, with reference to oocyte maturation. Concentrationsof IL-1 were significantly higher in the follicles from whichmature oocytes were recovered than in follicles from which oocytescould not be recovered (P < 0.05). IL-1 concentrations alsoincreased in association with oocyte maturation. Positive significantcorrelations were seen between IL-1 and prostaglandin E2 (PGE2)(r = 0.47, P < 0.001), and between IL-1 and prostaglandinF₂ (PGF₂) (r = 0.22, P < 0.05) in pre-ovulatory follicularfluid, but not between IL–1 and oestradiol, or betweenIL-1 and oestradiol, or between IL-1 and progesterone. 0Follicularfluid IL-1 might contribute to prostaglandin-induced oocytematuration and ovulation.     

Regulators of sperm function: Composition of the human zona pellucida and modifications following fertilization

The composition of individual human zonae pellucidae and modificationsto this extracellular coat both before and after fertilizationwere analysed using a rapid, sensitive, non-radioactive biotinylation-or lectin-based detection system; these assays use commerciallyavailable reagents and can be performed on fragments of individualzonae pellucidae. The zona pellucida from unfertilized eggsis composed of three glycoprotein species designated as huZP1,huZP2 and huZP3. Under non-reducing conditions, the molecularweights of these proteins are 150 kDa, 100 kDa, and 55–65kDa respectively. Following fertilization, huZP1 was not detectedunder either non-reducing or reducing conditions. In contrast,after fertilization huZP2 was detected under non-reducing conditions,but not under reducing conditions. The ability to detect pre-and postfertilization changes in a single human zona pellucidais discussed in relation to its value in assessing deficienciesin clinical and laboratory protocols used for in-vitro fertilization.     

Endocrinology: Substrate dependency of C19 conjugates in hirsute hyperandrogenic women and the influence of adrenal androgen

Serum C₁₉ conjugates, specifically 3-androstanediol glucuronide(3G), reflect peripheral androgen action through the actionof 5-reductase activity. The origin of 5-reduced C₁₉ conjugateshas been controversial and it has been suggested that they arederived primarily from adrenal androgens. We examined concentrationsof 3G, 3-androstanediol sulphate (3S), androsterone glucuronide(AoG) and androsterone sulphate (AoS) in 40 hirsute hyperandrogenicwomen. These patients were divided into four groups based uponindividual, combined or normal concentrations of the adrenalandrogens dehydroepiandrosterone (DHEAS) and 11-hydroxy-androstenedione.Testosterone, unbound testosterone and androstenedione weresimilar in these groups. Serum 3G was equally high in all groupsand was correlated significantly with hirsutism, while the otherconjugates were not. Androsterone glucuronide was raised inall groups but was higher in patients with raised DHEAS. Serum3S was raised in all groups and was higher where both adrenalandrogens were raised. Serum AoS was highly correlated withDHEAS. Serum 3G was correlated with unbound testosterone andandrostenedione but not with the adrenal androgens. The glucuronideconjugates were correlated with one another as were the sulphateconjugates but glucuronides and sulphates were not correlated.These data confirm ovarian and adrenal dependency of C₁₉ conjugates.Serum 3G appears to reflect hirsutism most accurately and isleast dependent on adrenal androgens in patients with mixedhyperandrogenism.     

Comparison of human chorionic gonadotrophin in human urine and amniotic fluid as estimated by a polyclonal and by a specific monoclonal assay in very early pregnancy

Urinary human chorionic gonadotrophin (HCG) was estimated in42 samples from patients in very early pregnancy or shortlyafter early spontaneous abortion, in which initial testing showeda positive urinary HCG in the Hybritech Tandem ICON II monoclonal2 min test. There were no false positives with this test evenwhen the blue colour was difficult to distinguish from the whitebackground, i.e. considerably less than the calibration bluespot at 50 mlU/ml. The Serono polyclonal -HCG radioimmunoassay(RIA) detected urinary intact HCG (plus free -subunit) at concentrationsas low as 10 mlU/ml IS 61/6 for bioassay (the old standard),i.e. 22mlU/ml 1st IRP 75/537 for immunoassay (the new standard).The LKB-Pharmacia DELFIA monoclonal fluoroimmunoassay (FIA)detected urinary intact HCG, without free -subunit, to a minimumconcentration of 18 mlU/ml 75/537. The proportion of monoclonal/polyclonalwas 2–155%. In normal amniotic fluid at 16–20 weeksof pregnancy, HCG concentrations were 3180? 2270 (755–11000) mlU/ml with the FIA.     

Immunology: Autoimmunity to spermatozoa, asymptomatic Chlamydia trachomatis genital tract infection and {gamma}{delta} T lymphocytes in seminal fluid from the male partners of couples with unexplained infertility

The relationship between an undetected, asymptomatic Chlamydiatrachomatis genital tract infection, the concentration of andb T cells in semen and sperm autoimmunity was examined in 48male partners of couples with unexplained infertility. ImmunoglobulinA (IgA) antibodies to C.trachomatis were detected in seminalfluids from 14 (29.2%) of the men. Only four of these were positivefor circulating anti-chlamydial IgA, suggesting that the stimulusfor antibody production was within the genital tract. In contrast,four men were positive for anti-chlamydial IgG in their semen;all were also seropositive for anti-chlamydial IgG. T lymphocytesbearing the and antigen receptors were present in every semensample. Men with seminal anti-chlamydial IgA, however, had significantly(P = 0.035) elevated semen T cell concentrations (median 3100cells/ml) than did men lacking this antibody (median 1400 cells/ml);concentrations of T cells were comparable in both groups. Genitaltract sperm autoimmunity, as shown by antibodies bound to motileejaculated spermatozoa, was detected in 13 (27.1%) men. Thepresence of these antibodies was associated with elevated concentrationsof both (median 4200 versus 700 cells/ml) and (median 5000versus 850 cells/ml) T cells (P = 0.0002 and 0.0001 respectively).Men with antisperm antibodies only in their serum had seminalT cell concentrations comparable with men testing negative forantisperm antibodies. Anti-chlamydial IgA was identified insemen from four of 10 men with IgA bound to their spermatozoaand in none of the men with only spermatozoabound IgG. Therewas no relationship between sperm quality and the occurrenceof seminal IgA antibodies to either C.trachomatis or spermatozoa.An asymptomatic C.trachomatis infection activates T cells withinthe male genital tract, which may lead to antisperm antibodyformation and immune-mediated infertility.     

Implantation: Tumour necrosis factor {alpha} inhibits in-vitro decidualization of human endometrial stromal cells

Interleukin-1 (IL-1) has been reported previously to inhibitthe in-vitro decidualization of human endometrial stromal cellsas assessed by progesterone-induced prolactin production andmorphological transformation. In this study we examined whetherother cytokines, such as tumour necrosis factor-(TNF), interferon-(IFN), IFN or granulocyte-macrophage colony-stimulating factor(GM-CSF), could affect the decidualization of human endometrialstromal cells in vitro. Of these cytokines, TNF significantlysuppressed prolactin production in a dose-dependent manner,with no apparent effect on cell number. The morphological transformationof endometrial stromal cells was also inhibited by TNF. TNFand IL-1 significantly suppressed cAMP-stimulated prolactinproduction by endometrial stromal cells. Neither the progesteroneconcentration in the supernatant of the endometrial stromalcell culture system nor intracellular calcium concentrationof the endometrial stromal cells were affected by the additionof TNF or IL-1. These results indicated that TNF and IL-1 suppressboth progesterone-induced and cAMP-mediated prolactin productionin endometrial stromal cells, and that this inhibition was notattributable to direct effects on progesterone metabolism orrelated to Ca2+-mediated signal transduction. These experimentssuggested that a local increase of TNF and IL-1 under certainpathological conditions in vivo may disturb blastocyst implantationand/or the maintenance of pregnancy by inhibiting the decidualizationof endometrial stromal cells.